| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pericardium | 4 | 2015 | 667 | 1.170 |
Why?
|
| Heart-Assist Devices | 7 | 2020 | 1194 | 1.150 |
Why?
|
| Aortic Valve | 6 | 2018 | 1922 | 1.000 |
Why?
|
| Myocardium | 16 | 2022 | 4776 | 0.970 |
Why?
|
| Heart Neoplasms | 5 | 2023 | 374 | 0.890 |
Why?
|
| Aorta | 5 | 2021 | 2061 | 0.870 |
Why?
|
| Thrombosis | 6 | 2020 | 2968 | 0.850 |
Why?
|
| Myocarditis | 7 | 2023 | 771 | 0.840 |
Why?
|
| Temporal Arteries | 2 | 2019 | 128 | 0.730 |
Why?
|
| Endocarditis, Bacterial | 3 | 2019 | 455 | 0.720 |
Why?
|
| Extracellular Matrix | 6 | 2014 | 1741 | 0.700 |
Why?
|
| Giant Cell Arteritis | 3 | 2019 | 292 | 0.670 |
Why?
|
| Heart Diseases | 5 | 2022 | 2788 | 0.650 |
Why?
|
| Drug Carriers | 8 | 2018 | 693 | 0.640 |
Why?
|
| Paclitaxel | 9 | 2020 | 1708 | 0.620 |
Why?
|
| Herpesvirus 3, Human | 1 | 2019 | 204 | 0.620 |
Why?
|
| Mitral Valve | 3 | 2017 | 1491 | 0.620 |
Why?
|
| Heart Defects, Congenital | 7 | 2018 | 4584 | 0.600 |
Why?
|
| Sarcoidosis | 6 | 2023 | 506 | 0.600 |
Why?
|
| Biocompatible Materials | 16 | 2015 | 1736 | 0.590 |
Why?
|
| Mesothelioma | 8 | 2023 | 818 | 0.570 |
Why?
|
| Nanoparticles | 10 | 2020 | 1905 | 0.560 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2017 | 97 | 0.550 |
Why?
|
| Cardiomyopathies | 12 | 2023 | 1912 | 0.550 |
Why?
|
| Heart Valve Diseases | 3 | 2018 | 1073 | 0.550 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 954 | 0.540 |
Why?
|
| Lung Neoplasms | 27 | 2023 | 13102 | 0.520 |
Why?
|
| Heart Transplantation | 13 | 2019 | 3110 | 0.520 |
Why?
|
| Heart | 9 | 2022 | 4467 | 0.510 |
Why?
|
| Autopsy | 13 | 2022 | 1020 | 0.510 |
Why?
|
| Bupivacaine | 5 | 2014 | 411 | 0.490 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.490 |
Why?
|
| Intestinal Mucosa | 3 | 2014 | 3036 | 0.490 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2015 | 194 | 0.490 |
Why?
|
| Antineoplastic Agents, Phytogenic | 6 | 2018 | 624 | 0.480 |
Why?
|
| T-Lymphocytes | 7 | 2019 | 10180 | 0.470 |
Why?
|
| Sciatic Nerve | 6 | 2014 | 607 | 0.470 |
Why?
|
| Aortic Diseases | 2 | 2018 | 742 | 0.450 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2013 | 117 | 0.430 |
Why?
|
| Heart Ventricles | 5 | 2019 | 3821 | 0.430 |
Why?
|
| Cardiology | 3 | 2021 | 1668 | 0.420 |
Why?
|
| Polymers | 12 | 2018 | 1621 | 0.420 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 264 | 0.410 |
Why?
|
| Pleural Neoplasms | 4 | 2023 | 607 | 0.410 |
Why?
|
| Lymphocyte Activation | 6 | 2019 | 5524 | 0.410 |
Why?
|
| Lung Diseases | 2 | 2015 | 1886 | 0.390 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 3537 | 0.390 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1607 | 0.380 |
Why?
|
| Tetralogy of Fallot | 1 | 2016 | 623 | 0.370 |
Why?
|
| Biopsy | 12 | 2023 | 6756 | 0.370 |
Why?
|
| Bioprosthesis | 4 | 2017 | 596 | 0.370 |
Why?
|
| Amyloid Neuropathies, Familial | 3 | 2018 | 138 | 0.370 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 3133 | 0.370 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 3240 | 0.360 |
Why?
|
| Heart Valve Prosthesis | 6 | 2017 | 1488 | 0.350 |
Why?
|
| Bone Morphogenetic Protein 2 | 5 | 2022 | 350 | 0.350 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2016 | 319 | 0.330 |
Why?
|
| Prosthesis-Related Infections | 3 | 2013 | 538 | 0.320 |
Why?
|
| Mycotoxins | 1 | 2008 | 36 | 0.320 |
Why?
|
| Device Removal | 3 | 2018 | 656 | 0.320 |
Why?
|
| Fatal Outcome | 7 | 2020 | 1850 | 0.320 |
Why?
|
| Animals | 97 | 2022 | 168757 | 0.310 |
Why?
|
| Amyloidosis | 3 | 2022 | 795 | 0.310 |
Why?
|
| Biological Specimen Banks | 3 | 2022 | 711 | 0.310 |
Why?
|
| Anesthetics, Local | 4 | 2014 | 985 | 0.310 |
Why?
|
| Prosthesis Failure | 4 | 2017 | 1206 | 0.300 |
Why?
|
| Biofilms | 2 | 2016 | 617 | 0.300 |
Why?
|
| Bone Regeneration | 3 | 2022 | 427 | 0.300 |
Why?
|
| Humans | 140 | 2024 | 744343 | 0.300 |
Why?
|
| Anesthesia, Local | 2 | 2006 | 275 | 0.300 |
Why?
|
| Delayed-Action Preparations | 3 | 2022 | 968 | 0.300 |
Why?
|
| Nerve Block | 4 | 2008 | 644 | 0.290 |
Why?
|
| Mannose-Binding Lectins | 1 | 2007 | 100 | 0.290 |
Why?
|
| Fluorodeoxyglucose F18 | 5 | 2021 | 2016 | 0.290 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2017 | 851 | 0.280 |
Why?
|
| Tissue Engineering | 11 | 2016 | 1880 | 0.280 |
Why?
|
| Heart Failure | 5 | 2018 | 10900 | 0.270 |
Why?
|
| Male | 84 | 2023 | 350118 | 0.270 |
Why?
|
| Pulmonary Artery | 3 | 2021 | 1912 | 0.270 |
Why?
|
| Tetrodotoxin | 1 | 2006 | 259 | 0.270 |
Why?
|
| Foreign-Body Reaction | 4 | 2017 | 157 | 0.270 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2007 | 171 | 0.260 |
Why?
|
| Drug Delivery Systems | 7 | 2018 | 2219 | 0.260 |
Why?
|
| Cattle | 14 | 2022 | 3922 | 0.260 |
Why?
|
| Prostheses and Implants | 6 | 2022 | 1387 | 0.260 |
Why?
|
| Graft Rejection | 7 | 2015 | 4397 | 0.260 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2018 | 1536 | 0.250 |
Why?
|
| Lung | 14 | 2023 | 9856 | 0.250 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2018 | 151 | 0.250 |
Why?
|
| Mice | 60 | 2021 | 81183 | 0.240 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 588 | 0.230 |
Why?
|
| Heart, Artificial | 2 | 2013 | 102 | 0.230 |
Why?
|
| Giant Cells | 2 | 2021 | 187 | 0.220 |
Why?
|
| Ovarian Neoplasms | 4 | 2013 | 4838 | 0.220 |
Why?
|
| Cryopreservation | 2 | 2020 | 670 | 0.220 |
Why?
|
| Female | 66 | 2023 | 380194 | 0.210 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2021 | 56 | 0.200 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2023 | 246 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2021 | 8301 | 0.200 |
Why?
|
| Lung Transplantation | 3 | 2015 | 1153 | 0.200 |
Why?
|
| Membranes, Artificial | 2 | 2009 | 378 | 0.200 |
Why?
|
| Positron-Emission Tomography | 7 | 2021 | 6234 | 0.200 |
Why?
|
| Middle Aged | 45 | 2021 | 213383 | 0.200 |
Why?
|
| Rats | 20 | 2022 | 24260 | 0.190 |
Why?
|
| Aged | 38 | 2023 | 163280 | 0.190 |
Why?
|
| Pulmonary Valve | 2 | 2018 | 437 | 0.190 |
Why?
|
| Materials Testing | 11 | 2014 | 867 | 0.190 |
Why?
|
| Myofibroblasts | 2 | 2012 | 222 | 0.190 |
Why?
|
| Thymus Neoplasms | 1 | 2023 | 268 | 0.190 |
Why?
|
| Cartilage, Articular | 4 | 2018 | 1095 | 0.180 |
Why?
|
| Wettability | 1 | 2019 | 24 | 0.180 |
Why?
|
| Adhesiveness | 1 | 2019 | 53 | 0.180 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2010 | 86 | 0.180 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 4 | 2007 | 91 | 0.180 |
Why?
|
| Cartilage | 5 | 2008 | 818 | 0.180 |
Why?
|
| Amyloidogenic Proteins | 2 | 2022 | 152 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 964 | 0.170 |
Why?
|
| Adhesives | 1 | 2019 | 61 | 0.170 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 4931 | 0.170 |
Why?
|
| Polyglactin 910 | 2 | 2014 | 59 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2011 | 1692 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2017 | 1133 | 0.170 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2012 | 434 | 0.170 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.170 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.170 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1999 | 185 | 0.170 |
Why?
|
| Hydrogen | 1 | 2019 | 164 | 0.170 |
Why?
|
| Prealbumin | 2 | 2022 | 210 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 4386 | 0.160 |
Why?
|
| Fibrosis | 4 | 2023 | 2029 | 0.160 |
Why?
|
| Hyaluronic Acid | 3 | 2015 | 491 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 3 | 2013 | 1351 | 0.160 |
Why?
|
| Receptors, Somatostatin | 1 | 2019 | 129 | 0.160 |
Why?
|
| Absorbable Implants | 4 | 2014 | 342 | 0.160 |
Why?
|
| Esophageal Fistula | 1 | 2018 | 64 | 0.160 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 729 | 0.160 |
Why?
|
| Carcinoma | 3 | 2018 | 2375 | 0.160 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 299 | 0.160 |
Why?
|
| Mutation | 14 | 2023 | 29786 | 0.160 |
Why?
|
| Shock, Cardiogenic | 2 | 2013 | 688 | 0.160 |
Why?
|
| Glucuronidase | 1 | 2019 | 207 | 0.160 |
Why?
|
| Ablation Techniques | 1 | 2021 | 249 | 0.160 |
Why?
|
| Femoral Vein | 1 | 2018 | 159 | 0.160 |
Why?
|
| Calcinosis | 3 | 2017 | 1499 | 0.150 |
Why?
|
| Peritoneal Neoplasms | 2 | 2016 | 665 | 0.150 |
Why?
|
| Germinal Center | 1 | 2020 | 377 | 0.150 |
Why?
|
| Transplantation, Homologous | 5 | 2013 | 4776 | 0.150 |
Why?
|
| Tachycardia, Ventricular | 3 | 2023 | 1273 | 0.150 |
Why?
|
| Peripheral Nerves | 1 | 2021 | 466 | 0.150 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.150 |
Why?
|
| Neoplasms | 5 | 2019 | 21683 | 0.150 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 57776 | 0.150 |
Why?
|
| Polyethylene Glycols | 6 | 2018 | 1182 | 0.150 |
Why?
|
| Dilatation, Pathologic | 1 | 2018 | 520 | 0.150 |
Why?
|
| Antigens, CD | 2 | 2007 | 4026 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2021 | 501 | 0.150 |
Why?
|
| Radiopharmaceuticals | 5 | 2021 | 2645 | 0.150 |
Why?
|
| Young Adult | 14 | 2022 | 56430 | 0.150 |
Why?
|
| Bone and Bones | 5 | 2016 | 2575 | 0.140 |
Why?
|
| Adenocarcinoma | 7 | 2010 | 6364 | 0.140 |
Why?
|
| DNA, Bacterial | 2 | 2019 | 1465 | 0.140 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2017 | 808 | 0.140 |
Why?
|
| Prosthesis Design | 3 | 2018 | 2110 | 0.140 |
Why?
|
| Glycoproteins | 3 | 2015 | 2263 | 0.140 |
Why?
|
| Chest Pain | 2 | 2013 | 1114 | 0.140 |
Why?
|
| Cell Line, Tumor | 17 | 2020 | 16689 | 0.140 |
Why?
|
| Actins | 3 | 2012 | 2121 | 0.140 |
Why?
|
| Osteogenesis | 4 | 2022 | 1299 | 0.140 |
Why?
|
| Cell Survival | 8 | 2020 | 5882 | 0.140 |
Why?
|
| Adult | 32 | 2024 | 214055 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2020 | 3557 | 0.130 |
Why?
|
| Signal Transduction | 9 | 2019 | 23403 | 0.130 |
Why?
|
| Nanofibers | 1 | 2015 | 66 | 0.130 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2017 | 177 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 644 | 0.130 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 665 | 0.130 |
Why?
|
| Saphenous Vein | 1 | 2018 | 532 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2015 | 126 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 847 | 0.130 |
Why?
|
| Iodide Peroxidase | 1 | 2017 | 293 | 0.130 |
Why?
|
| Triiodothyronine | 1 | 2017 | 494 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 118 | 0.130 |
Why?
|
| Mitral Valve Stenosis | 1 | 2017 | 376 | 0.130 |
Why?
|
| Graft Survival | 5 | 2015 | 3737 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2023 | 1253 | 0.130 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2015 | 87 | 0.130 |
Why?
|
| Stomach | 1 | 2019 | 697 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 986 | 0.130 |
Why?
|
| Ethylene Glycols | 1 | 2015 | 156 | 0.120 |
Why?
|
| Immunohistochemistry | 12 | 2015 | 11366 | 0.120 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2015 | 277 | 0.120 |
Why?
|
| Heart Atria | 2 | 2019 | 1357 | 0.120 |
Why?
|
| Lymphangiogenesis | 1 | 2015 | 172 | 0.120 |
Why?
|
| Safety | 1 | 2019 | 1186 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 1285 | 0.120 |
Why?
|
| Hypertrophy | 1 | 2016 | 569 | 0.120 |
Why?
|
| Antineoplastic Agents | 9 | 2015 | 13695 | 0.120 |
Why?
|
| Chondrocytes | 4 | 2008 | 804 | 0.120 |
Why?
|
| Risk Factors | 11 | 2024 | 72290 | 0.120 |
Why?
|
| Embolism | 1 | 2017 | 408 | 0.120 |
Why?
|
| Brain Edema | 1 | 2018 | 617 | 0.120 |
Why?
|
| Mice, Transgenic | 13 | 2017 | 9734 | 0.120 |
Why?
|
| Anhydrides | 2 | 2004 | 31 | 0.120 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 351 | 0.120 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2013 | 22 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2010 | 1660 | 0.110 |
Why?
|
| Smad1 Protein | 1 | 2013 | 81 | 0.110 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18029 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2022 | 41006 | 0.110 |
Why?
|
| Thyroxine | 1 | 2017 | 667 | 0.110 |
Why?
|
| Quinazolines | 3 | 2009 | 1356 | 0.110 |
Why?
|
| Microspheres | 2 | 2006 | 777 | 0.110 |
Why?
|
| Inflammation | 6 | 2023 | 10638 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 21827 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2017 | 399 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2019 | 2208 | 0.110 |
Why?
|
| Electrocardiography | 6 | 2017 | 6442 | 0.110 |
Why?
|
| Transplantation Tolerance | 2 | 2008 | 617 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 721 | 0.110 |
Why?
|
| Tissue Adhesives | 1 | 2014 | 179 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 183 | 0.100 |
Why?
|
| Glutarates | 1 | 2014 | 236 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2015 | 7880 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 2 | 2015 | 1965 | 0.100 |
Why?
|
| Heparin | 1 | 1999 | 1637 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2018 | 986 | 0.100 |
Why?
|
| Genes, ras | 4 | 2008 | 690 | 0.100 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2013 | 192 | 0.100 |
Why?
|
| Retrospective Studies | 15 | 2021 | 77449 | 0.100 |
Why?
|
| Capillaries | 1 | 2015 | 773 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2018 | 25625 | 0.100 |
Why?
|
| Myeloproliferative Disorders | 1 | 2018 | 606 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2014 | 2038 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2012 | 246 | 0.100 |
Why?
|
| Infant | 8 | 2022 | 35136 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 7 | 2015 | 6386 | 0.100 |
Why?
|
| Transplantation | 1 | 2013 | 217 | 0.100 |
Why?
|
| Costello Syndrome | 1 | 2011 | 19 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2014 | 349 | 0.100 |
Why?
|
| Bioreactors | 3 | 2008 | 236 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2019 | 35421 | 0.100 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2013 | 269 | 0.100 |
Why?
|
| Peritoneum | 2 | 2016 | 228 | 0.100 |
Why?
|
| Parvovirus B19, Human | 1 | 2010 | 38 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2018 | 1036 | 0.100 |
Why?
|
| High-Energy Shock Waves | 1 | 2011 | 36 | 0.100 |
Why?
|
| Histological Techniques | 1 | 2011 | 198 | 0.090 |
Why?
|
| Antibodies, Blocking | 3 | 2010 | 253 | 0.090 |
Why?
|
| Mice, Nude | 6 | 2016 | 3689 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 2015 | 0.090 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2010 | 60 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2015 | 986 | 0.090 |
Why?
|
| Periosteum | 1 | 2011 | 138 | 0.090 |
Why?
|
| Myocardial Stunning | 1 | 2010 | 68 | 0.090 |
Why?
|
| Liposomes | 1 | 2014 | 759 | 0.090 |
Why?
|
| Child | 11 | 2022 | 77709 | 0.090 |
Why?
|
| Cells, Cultured | 12 | 2019 | 19229 | 0.090 |
Why?
|
| Cell Proliferation | 8 | 2018 | 10481 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 381 | 0.090 |
Why?
|
| Adolescent | 10 | 2022 | 85781 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 514 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2017 | 5221 | 0.090 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 144 | 0.090 |
Why?
|
| Pharmaceutical Vehicles | 2 | 2012 | 59 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 544 | 0.090 |
Why?
|
| Implants, Experimental | 2 | 2012 | 104 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2016 | 407 | 0.090 |
Why?
|
| Myocytes, Cardiac | 3 | 2019 | 1637 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2017 | 1357 | 0.090 |
Why?
|
| Sarcomeres | 1 | 2012 | 374 | 0.090 |
Why?
|
| Th1 Cells | 2 | 2012 | 1057 | 0.090 |
Why?
|
| Time Factors | 10 | 2019 | 40075 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2010 | 648 | 0.090 |
Why?
|
| Cisplatin | 1 | 2015 | 1662 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2014 | 952 | 0.080 |
Why?
|
| Brain Death | 1 | 2012 | 348 | 0.080 |
Why?
|
| Knee Prosthesis | 1 | 2012 | 425 | 0.080 |
Why?
|
| Diphtheria Toxin | 2 | 2007 | 255 | 0.080 |
Why?
|
| Carboplatin | 2 | 2010 | 801 | 0.080 |
Why?
|
| Cross-Linking Reagents | 2 | 2019 | 694 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 611 | 0.080 |
Why?
|
| Bacteremia | 2 | 2013 | 962 | 0.080 |
Why?
|
| Endothelial Cells | 5 | 2021 | 3479 | 0.080 |
Why?
|
| Silicates | 1 | 2008 | 42 | 0.080 |
Why?
|
| Lactic Acid | 2 | 2006 | 1133 | 0.080 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2018 | 1052 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2018 | 1583 | 0.080 |
Why?
|
| Decanoates | 1 | 2008 | 54 | 0.080 |
Why?
|
| Neoplasm Metastasis | 4 | 2012 | 4851 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2022 | 1838 | 0.080 |
Why?
|
| Breast Implants | 1 | 2012 | 387 | 0.080 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 68 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 3 | 2011 | 1526 | 0.080 |
Why?
|
| Receptor, erbB-2 | 2 | 2009 | 2416 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2376 | 0.080 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2008 | 100 | 0.080 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2014 | 871 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 836 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2012 | 266 | 0.080 |
Why?
|
| Swine | 2 | 2019 | 5917 | 0.080 |
Why?
|
| Postoperative Complications | 5 | 2018 | 15295 | 0.080 |
Why?
|
| Endothelium, Vascular | 3 | 2014 | 4456 | 0.080 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 15165 | 0.080 |
Why?
|
| Stroke | 2 | 2023 | 9981 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1142 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 838 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 3670 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.080 |
Why?
|
| Sepsis | 2 | 2013 | 2593 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2012 | 578 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2019 | 14722 | 0.080 |
Why?
|
| Cell Differentiation | 7 | 2011 | 11483 | 0.080 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12959 | 0.080 |
Why?
|
| Heart Block | 1 | 2009 | 410 | 0.080 |
Why?
|
| Albumins | 1 | 2010 | 569 | 0.080 |
Why?
|
| Acrylamides | 1 | 2009 | 255 | 0.080 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 496 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2017 | 1422 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2010 | 964 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2019 | 2265 | 0.080 |
Why?
|
| Glycerol | 1 | 2008 | 278 | 0.070 |
Why?
|
| Immunoconjugates | 4 | 2012 | 901 | 0.070 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2007 | 96 | 0.070 |
Why?
|
| Receptors, Virus | 1 | 2010 | 648 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2009 | 5172 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2014 | 611 | 0.070 |
Why?
|
| Bronchial Neoplasms | 1 | 2007 | 112 | 0.070 |
Why?
|
| Kidney | 2 | 2021 | 7186 | 0.070 |
Why?
|
| Liver | 2 | 2021 | 7474 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 1114 | 0.070 |
Why?
|
| Tissue Donors | 2 | 2015 | 2240 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 479 | 0.070 |
Why?
|
| Sirolimus | 3 | 2009 | 1564 | 0.070 |
Why?
|
| Myoblasts | 1 | 2008 | 238 | 0.070 |
Why?
|
| Polyesters | 2 | 2018 | 363 | 0.070 |
Why?
|
| S100 Proteins | 1 | 2007 | 259 | 0.070 |
Why?
|
| Hip Prosthesis | 1 | 2012 | 917 | 0.070 |
Why?
|
| Magnetics | 1 | 2009 | 606 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2012 | 5535 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2018 | 1276 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2019 | 4445 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 849 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1832 | 0.070 |
Why?
|
| Specimen Handling | 1 | 2011 | 694 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2021 | 20129 | 0.070 |
Why?
|
| Bone Marrow Cells | 3 | 2013 | 2513 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2569 | 0.070 |
Why?
|
| ras Proteins | 1 | 2011 | 1060 | 0.070 |
Why?
|
| Recurrence | 5 | 2015 | 8340 | 0.070 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2007 | 337 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2013 | 2635 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 813 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2014 | 2132 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 476 | 0.060 |
Why?
|
| Cell Communication | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Mice, Mutant Strains | 4 | 2010 | 1866 | 0.060 |
Why?
|
| Acrylic Resins | 2 | 2019 | 142 | 0.060 |
Why?
|
| Connective Tissue | 2 | 2005 | 420 | 0.060 |
Why?
|
| Viral Load | 3 | 2021 | 3299 | 0.060 |
Why?
|
| Metal Nanoparticles | 1 | 2009 | 405 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 2 | 2011 | 2007 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1061 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 2006 | 407 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 4740 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2017 | 364 | 0.060 |
Why?
|
| Peptides | 2 | 2007 | 4409 | 0.060 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 437 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2019 | 10943 | 0.060 |
Why?
|
| Fractures, Spontaneous | 1 | 2006 | 230 | 0.060 |
Why?
|
| Heart Valves | 1 | 2006 | 291 | 0.060 |
Why?
|
| Patella | 1 | 2006 | 320 | 0.060 |
Why?
|
| Pandemics | 5 | 2023 | 8388 | 0.060 |
Why?
|
| Dextrans | 1 | 2006 | 595 | 0.060 |
Why?
|
| Disease Progression | 5 | 2024 | 13284 | 0.060 |
Why?
|
| Blood Vessels | 2 | 2002 | 1125 | 0.060 |
Why?
|
| Neutrophils | 2 | 2014 | 3719 | 0.060 |
Why?
|
| Mammals | 1 | 2009 | 1143 | 0.060 |
Why?
|
| Cause of Death | 3 | 2021 | 3584 | 0.060 |
Why?
|
| Epithelium | 1 | 2008 | 1679 | 0.060 |
Why?
|
| Immunoglobulin D | 1 | 2023 | 56 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 1265 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2018 | 2942 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 29063 | 0.060 |
Why?
|
| Nanostructures | 1 | 2008 | 551 | 0.060 |
Why?
|
| Perfusion | 1 | 2008 | 1360 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2008 | 1159 | 0.060 |
Why?
|
| Models, Chemical | 2 | 2009 | 626 | 0.060 |
Why?
|
| Epinephrine | 1 | 2006 | 792 | 0.060 |
Why?
|
| Mice, Knockout | 6 | 2021 | 14557 | 0.060 |
Why?
|
| Receptors, CXCR5 | 1 | 2023 | 92 | 0.060 |
Why?
|
| Hydrogels | 3 | 2019 | 724 | 0.060 |
Why?
|
| Metaplasia | 2 | 2015 | 313 | 0.060 |
Why?
|
| Prostatic Hyperplasia | 1 | 2007 | 523 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3107 | 0.050 |
Why?
|
| Phenotype | 4 | 2019 | 16365 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 1581 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2010 | 2938 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2011 | 1401 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1146 | 0.050 |
Why?
|
| Penile Induration | 1 | 2002 | 16 | 0.050 |
Why?
|
| Feasibility Studies | 3 | 2021 | 5078 | 0.050 |
Why?
|
| Europe | 3 | 2015 | 3339 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1632 | 0.050 |
Why?
|
| Kinetics | 3 | 2018 | 6473 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2010 | 627 | 0.050 |
Why?
|
| Pneumonectomy | 2 | 2020 | 1094 | 0.050 |
Why?
|
| Treatment Outcome | 8 | 2021 | 63114 | 0.050 |
Why?
|
| Benzothiazoles | 1 | 2022 | 248 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 1723 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2005 | 575 | 0.050 |
Why?
|
| Vitamin D | 1 | 2015 | 3223 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3474 | 0.050 |
Why?
|
| Carbon | 1 | 2005 | 687 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4751 | 0.050 |
Why?
|
| Biomedical Engineering | 2 | 2001 | 296 | 0.050 |
Why?
|
| Composite Resins | 1 | 2000 | 74 | 0.050 |
Why?
|
| Age Distribution | 2 | 2018 | 2902 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 3327 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 23338 | 0.050 |
Why?
|
| Dexamethasone | 2 | 2005 | 1951 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2021 | 53288 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2022 | 1541 | 0.050 |
Why?
|
| Penile Neoplasms | 1 | 2002 | 160 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1839 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2002 | 1224 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9239 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 449 | 0.050 |
Why?
|
| Cell Membrane Permeability | 2 | 2012 | 590 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 784 | 0.050 |
Why?
|
| World Health Organization | 2 | 2021 | 1318 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2009 | 3768 | 0.050 |
Why?
|
| Membrane Lipids | 1 | 2021 | 248 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3508 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2020 | 1915 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 193 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2003 | 927 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3870 | 0.040 |
Why?
|
| Desiccation | 1 | 2019 | 70 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 236 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2019 | 19905 | 0.040 |
Why?
|
| Hemangiosarcoma | 1 | 2002 | 239 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2021 | 21746 | 0.040 |
Why?
|
| Membrane Fusion | 1 | 2021 | 273 | 0.040 |
Why?
|
| Elasticity | 2 | 2014 | 657 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2019 | 293 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2021 | 4161 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 297 | 0.040 |
Why?
|
| Methotrexate | 1 | 2006 | 1727 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2015 | 2255 | 0.040 |
Why?
|
| Gout | 1 | 2006 | 573 | 0.040 |
Why?
|
| Injections | 2 | 2014 | 840 | 0.040 |
Why?
|
| Static Electricity | 1 | 2019 | 267 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2011 | 3743 | 0.040 |
Why?
|
| Osteophyte | 1 | 2018 | 45 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2014 | 859 | 0.040 |
Why?
|
| Dendrimers | 1 | 2018 | 68 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2007 | 880 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 2737 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 141 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2022 | 545 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 4034 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 2988 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 1999 | 250 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 2268 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 1970 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 675 | 0.040 |
Why?
|
| Particle Size | 3 | 2008 | 1642 | 0.040 |
Why?
|
| DNA | 2 | 2009 | 7301 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2008 | 8428 | 0.040 |
Why?
|
| Technetium | 1 | 2018 | 334 | 0.040 |
Why?
|
| Gelatin | 1 | 2019 | 225 | 0.040 |
Why?
|
| Prevalence | 4 | 2017 | 15226 | 0.040 |
Why?
|
| Coronary Circulation | 2 | 2014 | 1572 | 0.040 |
Why?
|
| Pericarditis | 1 | 2019 | 128 | 0.040 |
Why?
|
| Death Certificates | 1 | 2018 | 169 | 0.040 |
Why?
|
| Succinic Acid | 1 | 2018 | 83 | 0.040 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2017 | 87 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39050 | 0.040 |
Why?
|
| Amyloid | 1 | 2022 | 795 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2014 | 2073 | 0.040 |
Why?
|
| Hydrolases | 1 | 2018 | 139 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 182 | 0.040 |
Why?
|
| Equipment Contamination | 1 | 2018 | 185 | 0.040 |
Why?
|
| Hypotension | 2 | 2013 | 884 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2002 | 683 | 0.040 |
Why?
|
| Lactates | 1 | 1998 | 432 | 0.040 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2017 | 173 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3752 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9274 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3798 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2010 | 675 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2021 | 895 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5097 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2007 | 2494 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2019 | 374 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 11524 | 0.040 |
Why?
|
| NIH 3T3 Cells | 2 | 2009 | 677 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 1341 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2007 | 2043 | 0.040 |
Why?
|
| Ultrasonography | 3 | 2015 | 5985 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2009 | 8436 | 0.040 |
Why?
|
| Joints | 1 | 2018 | 326 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2018 | 244 | 0.040 |
Why?
|
| Respiratory System | 1 | 2020 | 557 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2012 | 5974 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1270 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1105 | 0.030 |
Why?
|
| Stromal Cells | 2 | 2001 | 1355 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2017 | 323 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 2872 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2021 | 2008 | 0.030 |
Why?
|
| Indocyanine Green | 1 | 2017 | 239 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 643 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2002 | 1166 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9648 | 0.030 |
Why?
|
| Survival Rate | 3 | 2015 | 12788 | 0.030 |
Why?
|
| Cellulose | 1 | 1996 | 121 | 0.030 |
Why?
|
| Molecular Structure | 3 | 2006 | 1899 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 2015 | 43 | 0.030 |
Why?
|
| Porosity | 2 | 2008 | 362 | 0.030 |
Why?
|
| Cytokines | 3 | 2021 | 7322 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2003 | 1023 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2021 | 862 | 0.030 |
Why?
|
| Collagen | 3 | 2014 | 2689 | 0.030 |
Why?
|
| Th2 Cells | 2 | 2012 | 1061 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 2085 | 0.030 |
Why?
|
| Gentamicins | 1 | 2016 | 255 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1676 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
| Vasculitis | 1 | 2019 | 519 | 0.030 |
Why?
|
| Moraxellaceae Infections | 1 | 2014 | 8 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 528 | 0.030 |
Why?
|
| DNA Primers | 2 | 2012 | 2892 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1999 | 1460 | 0.030 |
Why?
|
| Skin | 1 | 2008 | 4364 | 0.030 |
Why?
|
| Emergencies | 1 | 2021 | 1170 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 1821 | 0.030 |
Why?
|
| Keratin-15 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2014 | 48 | 0.030 |
Why?
|
| Autoradiography | 1 | 2015 | 745 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Propionibacterium acnes | 1 | 2014 | 66 | 0.030 |
Why?
|
| Gene Expression Profiling | 4 | 2014 | 9438 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 4665 | 0.030 |
Why?
|
| Pneumonia | 1 | 2006 | 2133 | 0.030 |
Why?
|
| Spleen | 1 | 2020 | 2362 | 0.030 |
Why?
|
| Exons | 2 | 2013 | 2437 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8642 | 0.030 |
Why?
|
| Alkaline Phosphatase | 2 | 2011 | 865 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 8949 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2014 | 98 | 0.030 |
Why?
|
| Comorbidity | 2 | 2021 | 10388 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2018 | 2031 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2009 | 1375 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 209 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7279 | 0.030 |
Why?
|
| Rubidium Radioisotopes | 1 | 2013 | 85 | 0.030 |
Why?
|
| Orthopedics | 1 | 2003 | 904 | 0.030 |
Why?
|
| Boston | 2 | 2017 | 9313 | 0.030 |
Why?
|
| Macrophages | 3 | 2014 | 5655 | 0.030 |
Why?
|
| Chondrogenesis | 2 | 2005 | 247 | 0.030 |
Why?
|
| Cell Line | 3 | 2014 | 15997 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2014 | 335 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 6314 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26385 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12208 | 0.030 |
Why?
|
| Water | 1 | 2019 | 1395 | 0.030 |
Why?
|
| Photochemistry | 2 | 2004 | 238 | 0.030 |
Why?
|
| Protein Binding | 2 | 2015 | 9386 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 1537 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2014 | 291 | 0.030 |
Why?
|
| Hyperemia | 1 | 2014 | 225 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 956 | 0.030 |
Why?
|
| Drug Design | 2 | 2010 | 1076 | 0.030 |
Why?
|
| Diffusion | 2 | 2005 | 833 | 0.030 |
Why?
|
| Membranes | 1 | 2012 | 173 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 814 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2021 | 2902 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 284 | 0.030 |
Why?
|
| Organ Preservation | 1 | 2015 | 331 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 4217 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2012 | 2540 | 0.030 |
Why?
|
| Models, Animal | 2 | 2010 | 2171 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6538 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 437 | 0.030 |
Why?
|
| Cecum | 1 | 2013 | 237 | 0.030 |
Why?
|
| Durapatite | 1 | 2013 | 161 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 2649 | 0.030 |
Why?
|
| Echocardiography | 2 | 2018 | 5102 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2012 | 2455 | 0.030 |
Why?
|
| Cholesterol | 1 | 2021 | 2917 | 0.030 |
Why?
|
| Zebrafish | 2 | 2013 | 2994 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4479 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2010 | 3616 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 496 | 0.030 |
Why?
|
| United States | 5 | 2021 | 69872 | 0.030 |
Why?
|
| Surgical Mesh | 1 | 2014 | 276 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 3701 | 0.030 |
Why?
|
| Hemolysis | 1 | 2013 | 420 | 0.030 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2011 | 54 | 0.030 |
Why?
|
| Quinolines | 2 | 2007 | 732 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 547 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2011 | 130 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 1261 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 341 | 0.020 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 353 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 399 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2018 | 832 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2011 | 90 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2011 | 126 | 0.020 |
Why?
|
| Parvoviridae Infections | 1 | 2010 | 35 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2557 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 2012 | 492 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 658 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 387 | 0.020 |
Why?
|
| Dihydroxyacetone | 1 | 2010 | 8 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2021 | 9146 | 0.020 |
Why?
|
| Coronary Angiography | 2 | 2015 | 4577 | 0.020 |
Why?
|
| Prednisone | 1 | 2015 | 1574 | 0.020 |
Why?
|
| Apoptosis | 4 | 2008 | 9727 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2015 | 924 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2203 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Polycarboxylate Cement | 1 | 2010 | 18 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6114 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1743 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12245 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15076 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2011 | 273 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2019 | 8324 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 532 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2012 | 546 | 0.020 |
Why?
|
| Seroma | 1 | 2010 | 71 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2010 | 2109 | 0.020 |
Why?
|
| Image Enhancement | 2 | 2012 | 2921 | 0.020 |
Why?
|
| Epididymal Secretory Proteins | 1 | 2009 | 12 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2013 | 525 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1901 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 2924 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 1028 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 13881 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1917 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2018 | 40561 | 0.020 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2009 | 52 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2009 | 57 | 0.020 |
Why?
|
| Breast Implantation | 1 | 2012 | 218 | 0.020 |
Why?
|
| Models, Biological | 2 | 2012 | 9583 | 0.020 |
Why?
|
| Peritonitis | 1 | 2011 | 365 | 0.020 |
Why?
|
| Surface Properties | 2 | 2005 | 1184 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2015 | 1200 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2015 | 2971 | 0.020 |
Why?
|
| Fluorescein | 1 | 2009 | 171 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 881 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 4149 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 25043 | 0.020 |
Why?
|
| Ileum | 1 | 2011 | 565 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2011 | 361 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3690 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1060 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 4420 | 0.020 |
Why?
|
| Uteroglobin | 1 | 2008 | 58 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2009 | 330 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2013 | 711 | 0.020 |
Why?
|
| Polycythemia | 1 | 2009 | 126 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2010 | 428 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 1401 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 1775 | 0.020 |
Why?
|
| Elastomers | 1 | 2008 | 71 | 0.020 |
Why?
|
| Gels | 1 | 2009 | 427 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2010 | 549 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 1100 | 0.020 |
Why?
|
| Survival | 1 | 2008 | 163 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 11031 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 434 | 0.020 |
Why?
|
| Contrast Media | 2 | 2012 | 5300 | 0.020 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2013 | 554 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2009 | 290 | 0.020 |
Why?
|
| Base Sequence | 2 | 2012 | 12797 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18370 | 0.020 |
Why?
|
| Sheep | 1 | 2010 | 1437 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 4982 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 1585 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2007 | 223 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1972 | 0.020 |
Why?
|
| Cell Movement | 3 | 2011 | 5217 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2009 | 3420 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 895 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2015 | 1873 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2007 | 517 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2013 | 1539 | 0.020 |
Why?
|
| H-2 Antigens | 1 | 2007 | 366 | 0.020 |
Why?
|
| Motion | 1 | 2011 | 798 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2008 | 666 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 669 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 157 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8664 | 0.020 |
Why?
|
| Syncope | 1 | 2010 | 429 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2010 | 10252 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2007 | 11124 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 1856 | 0.020 |
Why?
|
| Mitochondria | 2 | 2010 | 3520 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2018 | 1797 | 0.020 |
Why?
|
| Endothelium | 1 | 2009 | 778 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2009 | 620 | 0.020 |
Why?
|
| Connective Tissue Cells | 1 | 2006 | 55 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7181 | 0.020 |
Why?
|
| Esters | 1 | 2007 | 210 | 0.020 |
Why?
|
| Mesoderm | 1 | 2009 | 686 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2421 | 0.020 |
Why?
|
| Ethanol | 1 | 2012 | 1342 | 0.020 |
Why?
|
| Systems Integration | 1 | 2008 | 440 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2008 | 608 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2006 | 414 | 0.020 |
Why?
|
| Excipients | 1 | 2005 | 96 | 0.020 |
Why?
|
| Doxycycline | 1 | 2007 | 326 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 493 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 376 | 0.020 |
Why?
|
| Sterilization | 1 | 2006 | 133 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 1842 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 18111 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 880 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 20822 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2258 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 868 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2440 | 0.020 |
Why?
|
| Tibia | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 2133 | 0.020 |
Why?
|
| Fibrillar Collagens | 1 | 2005 | 41 | 0.020 |
Why?
|
| Acute Disease | 1 | 2015 | 7149 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2007 | 755 | 0.020 |
Why?
|
| Wound Healing | 1 | 2016 | 2785 | 0.020 |
Why?
|
| Linear Models | 1 | 2015 | 5952 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 1751 | 0.020 |
Why?
|
| Femur | 1 | 2011 | 1297 | 0.020 |
Why?
|
| Melanoma | 1 | 2003 | 5510 | 0.020 |
Why?
|
| Elastin | 1 | 2006 | 308 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2008 | 890 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 2460 | 0.020 |
Why?
|
| Pressure | 1 | 2008 | 1203 | 0.020 |
Why?
|
| Silicon | 1 | 2005 | 145 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 2250 | 0.020 |
Why?
|
| Respiration | 1 | 2011 | 1653 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2004 | 476 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2014 | 2924 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2011 | 1431 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2007 | 415 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2010 | 2225 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3206 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 768 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2564 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8663 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 472 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2006 | 644 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 705 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 2006 | 407 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 552 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 961 | 0.010 |
Why?
|
| Carbohydrates | 1 | 2005 | 394 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2715 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7913 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 2726 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 1686 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2009 | 951 | 0.010 |
Why?
|
| Temperature | 1 | 2009 | 2206 | 0.010 |
Why?
|
| Stents | 1 | 2015 | 3280 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2006 | 435 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2005 | 247 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 638 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 1097 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 1855 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3617 | 0.010 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2008 | 541 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 7729 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2647 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2007 | 1074 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12261 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2014 | 4217 | 0.010 |
Why?
|
| Plasmids | 1 | 2007 | 2307 | 0.010 |
Why?
|
| Mastectomy | 1 | 2010 | 1793 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9687 | 0.010 |
Why?
|
| Length of Stay | 1 | 2015 | 6309 | 0.010 |
Why?
|
| Benzamides | 1 | 2007 | 1379 | 0.010 |
Why?
|
| Glycerophosphates | 1 | 2001 | 48 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 6622 | 0.010 |
Why?
|
| Subcutaneous Tissue | 1 | 2002 | 135 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2886 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2645 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1641 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5179 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2008 | 3002 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 13989 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2008 | 1640 | 0.010 |
Why?
|
| Registries | 1 | 2017 | 8089 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 1998 | 2699 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1581 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3200 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2013 | 5007 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 554 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2006 | 2716 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2000 | 169 | 0.010 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 2337 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7722 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2006 | 1241 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3582 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2009 | 5456 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2006 | 1578 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 1312 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3846 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2050 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 1643 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1547 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2001 | 624 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3144 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13815 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 330 | 0.010 |
Why?
|
| Fetus | 1 | 2006 | 1880 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1998 | 219 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6489 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.010 |
Why?
|
| Biotinylation | 1 | 1998 | 179 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1998 | 225 | 0.010 |
Why?
|
| Microscopy, Atomic Force | 1 | 1998 | 250 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 8987 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3493 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Skull | 1 | 2002 | 813 | 0.010 |
Why?
|
| Knee Joint | 1 | 2006 | 1680 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 13033 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3507 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 5751 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 5892 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 2382 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1998 | 982 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1790 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 7023 | 0.010 |
Why?
|
| Weight Loss | 1 | 2006 | 2622 | 0.010 |
Why?
|
| Lipids | 1 | 2005 | 3305 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11727 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3703 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1998 | 1678 | 0.010 |
Why?
|
| Proteins | 1 | 2005 | 6103 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4568 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6487 | 0.010 |
Why?
|
| Insulin | 1 | 2001 | 6580 | 0.000 |
Why?
|
| Stem Cells | 1 | 1998 | 3567 | 0.000 |
Why?
|